Article
Microbiome-based biomarkers to guide personalized microbiome-based therapies for Parkinson’s disease
2024-04-04
Abstract excerpt
We address an unmet challenge in Parkinson’s disease: the lack of biomarkers to identify the right patients for the right therapy, which is a main reason clinical trials for disease modifying treatments have all failed. The gut microbiome is a new target for treatment of Parkinson’s disease, with potential to halt disease progression. Our aim was to develop microbiome-based biomarkers to guide patient selection fo...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1dde3183-02ee-5a25-994c-78e5610f666a
- DOI
- 10.1101/2024.04.03.24305273
